Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis

Journal of Alzheimer's Disease

Volumn 50, Issue 1, 2016, Pages 13-17

  Gao, Lei ^a   Cui, Zhen ^a   Shen, Liang ^a   Ji, Hong Fang ^a  

^a SHANDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; bioinformatics; genetic basis; genome wide association studies; SNPs; type 2 diabetes

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BIOINFORMATICS; GENETIC ASSOCIATION; HEREDITY; HUMAN; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGY; FACTUAL DATABASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MALE; PROCEDURES; STATISTICS AND NUMERICAL DATA;

APOLIPOPROTEIN C-I, HUMAN; APOLIPOPROTEIN C1;

ALZHEIMER DISEASE; APOLIPOPROTEIN C-I; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LIPID METABOLISM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84954123894     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150580     Document Type: Article

References (27)

1. Ley SH, Hamdy O, Mohan V, Hu FB (2014) Prevention and management of type 2 diabetes: Dietary components and nutritional strategies. Lancet 383, 1999-2007.
2. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10, 819-828.
3. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, BretelerMM(1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53, 1937-1942.
4. Profenno LA, Porsteinsson AP, Faraone SV (2010) Metaanalysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 67, 505-512.
5. Schrijvers EM, Witteman JC, Sijbrands EJ, Hofman A, Koudstaal PJ, BretelerMM(2010) Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study. Neurology 75, 1982-1987.
6. den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, Breteler MM (2003) Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46, 1604-1610.
7. Pasquier F, Boulogne A, Leys D, Fontaine P (2006) Diabetes mellitus and dementia. Diabetes Metab 32, 403-414.
8. Duarte AI, Moreira PI, Oliveira CR. (2012) Insulin in central nervous system: More than just a peripheral hormone. J Aging Res 2012, 384017
9. Lourenco MV, Clarke JR, Frozza RL, Bomfim TR, Forny-Germano L, Batista AF, Sathler LB, Brito-Moreira J, Amaral OB, Silva CA, Freitas-Correa L, Espirito-Santo S, Campello-Costa P, Houzel JC, Klein WL, Holscher C, Carvalheira JB, Silva AM, Velloso LA, Munoz DP, Ferreira ST, De Felice FG (2013) TNF-alpha mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's beta-amyloid oligomers in mice and monkeys. Cell Metab 18, 831-843.
10. Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL (2008) Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 22, 246-260.
11. De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP, Viola KL, Zhao WQ, Ferreira ST, Klein WL(2009) Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci U S A 106, 1971-1976.
12. Ward LD, Kellis M (2012) HaploReg: A resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 40, D930-D934.
13. Genomes Project C, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME,McVean GA (2010) A map of human genome variation from populationscale sequencing. Nature 467, 1061-1073.
14. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57.
15. Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, BeechamGW, Rajbhandary RA, Hamilton-Nelson KL,Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, Baldwin CT, Jarvik GP, Crane PK, Rogaeva E, Barmada MM, Demirci FY, Cruchaga C, Kramer PL, Ertekin-Taner N, Hardy J, Graff-Radford NR, Green RC, Larson EB, St George-Hyslop PH, Buxbaum JD, Evans DA, Schneider JA, Lunetta KL, Kamboh MI, Saykin AJ, Reiman EM, De Jager PL, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, TsuangDW, Hakonarson H,KukullWA, Foroud TM,Martin ER, Haines JL, Mayeux RP, Farrer LA, Schellenberg GD, Pericak-Vance MA, Alzheimer Disease Genetics Consortium, Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barnes LL, Beach TG, Becker JT, Beekly D, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carney RM, Carrasquillo MM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cribbs DH, Crocco EA, DeCarli C, DeKosky ST, Dick M, Dickson DW, Duara R, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lin CF, Lopez OL, Lyketsos CG, Mack WJ, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Murrell JR, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Valladares O, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L (2014) Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease:AGenome-Wide Association Study. JAMA Neurol 71, 1394-1404.
16. Irie F, Fitzpatrick AL, Lopez OL,Kuller LH, Peila R, Newman AB, Launer LJ (2008) Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: The Cardiovascular Health Study Cognition Study. Arch Neurol 65, 89-93.
17. Peila R, Rodriguez BL, Launer LJ, Honolulu-Asia Aging, Study (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 1256-1262.
18. Berbee JF,VanmierloT, Abildayeva K, Blokland A, Jansen PJ, Lutjohann D, Gautier T, Sijbrands E, Prickaerts J, Hadfoune M, Ramaekers FC, Kuipers F, Rensen PC, Mulder M (2011) Apolipoprotein CI knock-out mice display impaired memory functions. J Alzheimers Dis 23, 737-747.
19. Abildayeva K, Berbee JF, Blokland A, Jansen PJ, Hoek FJ, Meijer O, Lutjohann D, Gautier T, Pillot T, De Vente J, Havekes LM, Ramaekers FC, Kuipers F, Rensen PC, Mulder M (2008) Human apolipoprotein C-I expression in mice impairs learning and memory functions. J Lipid Res 49, 856-869.
20. McKay GJ, Savage DA, Patterson CC, Lewis G, McKnight AJ, Maxwell AP, Warren UKGSG. (2013) Association analysis of dyslipidemia-related genes in diabetic nephropathy. PLoS One 8, e58472
21. McKnight AJ, Maxwell AP, Fogarty DG, Sadlier D, Savage DA, Warren 3/UK, Study GoKinD, Group (2009) Genetic analysis of coronary artery disease single-nucleotide polymorphisms in diabetic nephropathy. Nephrol Dial Transpl 24, 2473-2476.
22. Tang W, Shi YQ, Zou JJ, Chen XF, Zheng JY, Zhao SW, Liu ZM (2011) Serum biomarker of diabetic peripheral neuropathy indentified by differential proteomics. Front Biosci 16, 2671-2681.
23. Hansen HG, Overgaard J, Lajer M, Hubalek F, Hojrup P, Pedersen L, Tarnow L, Rossing P, Pociot F, McGuire JN (2010) Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis. Proteom Clin Appl 4, 697-705.
24. Mooyaart AL, Valk EJ, van Es LA, Bruijn JA, de Heer E, Freedman BI, Dekkers OM, Baelde HJ (2011) Genetic associations in diabetic nephropathy:Ameta-analysis. Diabetologia 54, 544-553.
25. Muurling M, van den Hoek AM, Mensink RP, Pijl H, Romijn JA,HavekesLM,Voshol PJ (2004) Overexpression ofAPOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance. J Lipid Res 45, 9-16.
26. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 7, 63-80.
27. Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 31, 224-243.